Microcarriers Market Size, Scope, Growth & Outlook 2030
[Research Report] The microcarriers market size is projected to grow from US$ 1,625.84 million in 2022 to US$ 4,178.86 million by 2030; the market is estimated to record a CAGR of 12.5% during 2022-2030.
Market Insights and Analyst View:
Microcarriers are used in a variety of applications, from cell culture to drug delivery. They are employed to stimulate the growth of cells in culture media by providing a larger surface area for cell attachment. They can be used in applications such as vaccine production, biopharmaceuticals, and stem cell research. The microcarrier market's growth is attributed to the growing demand for cell-based vaccines and therapeutics, the rising incidence of various diseases and disorders like diabetes, cancer, hemophilia, rheumatoid arthritis, and others, huge investments for the development of innovative therapies, and consistent technological advancements in cell biology research.
Companies operating in the microcarriers market are focusing on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. For instance, in October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US.
Growth Drivers:
Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
World Health Organization (WHO) states that the global burden of cancer is estimated to rise to 27.5 million new cases and 16.3 million mortalities by 2040. The American Cancer Society projected 1,918,030 new cancer cases and 609,360 related deaths in the US for the year 2022, including nearly 350 deaths/day from lung cancer, which is a major cause of cancer mortality. According to the Australian Institute of Health and Welfare, there were more than 324,000 hospitalizations for infectious diseases, and more than 4,700 hospitalizations due to COVID-19 infection in Australia in 2020–2021. Further, a total of 1.6 million people died from tuberculosis (TB) in 2021 (including 187,000 people with HIV). TB ranks 13th in the leading causes of mortality and 2nd among the major causes of deaths due to infectious diseases worldwide, after COVID-19 (above HIV and AIDS).
The increasing incidence of diseases where cell therapy can be effectively applied, such as cancers, urinary problems, autoimmune diseases, and infectious diseases, is associated with the growth of the microcarriers market. Microcarriers are small spheres or particles (typically 90–300 µm in diameter) used for culturing adherent cells in stirred-tank bioreactors. With the growing incidence of cancer and various infectious diseases, the need for proper medication and vaccines arises, which favors the microcarriers market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Microcarriers Market: Strategic Insights
Market Size Value in US$ 1,625.84 million in 2022 Market Size Value by US$ 4,178.86 million by 2030 Growth rate CAGR of 12.5% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Microcarriers Market: Strategic Insights
| Market Size Value in | US$ 1,625.84 million in 2022 |
| Market Size Value by | US$ 4,178.86 million by 2030 |
| Growth rate | CAGR of 12.5% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “microcarriers market” is segmented on the basis of product, equipment, application, and end user. Based on product, the market is bifibracted into microcarrier beads and media & reagents. The microcarriers market, by equipment, is segmented into bioreactors, culture vessels, and others. Based on application, the market is segregated into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. The biopharmaceutical production segment is subsegmented into therapeutic protein and vaccine production. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations, and academic and research institutes.
Segmental Analysis:
Based on product, the microcarriers market is divided into microcarrier beads, and media and reagents. In 2022, the microcarrier beads segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022–2030. Growing cell biology research, demand for regenerative medicines and biopharmaceuticals, and the presence of multiple manufacturers and suppliers contribute to the considerable market growth of microcarrier beads. Extensive product offerings and continuous developments in microcarrier technology offer lucrative opportunities for the growth of key market players. Major companies such as Sartorius AG offer microcarrier beads that are free of animal components and proteins coated.
Based on equipment, the microcarriers market is segmented into bioreactors, culture vessels, and others. In 2022, the bioreactors segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022–2030. Bioreactors are manufacturing devices or vessels in which biological reactions are carried out; they are used to grow microorganisms such as yeast, bacteria, or animal cells in an appropriate environment under controlled conditions. A microcarrier-based bioreactor allows the real-time off-line monitoring of cell growth, and quality and metabolite analyses, which can be utilized to detect errors and rectify them immediately.
Based on application, the microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. In 2022, the biopharmaceutical production segment held the largest market share, and the same is estimated to register the fastest CAGR of 13.1% during 2022–2030. The biopharmaceutical production segment is further subsegmented into therapeutic production and vaccine production. Microcarriers are an established technology in the biopharmaceutical industry, which, in combination with stirred-tank bioreactors, can provide the necessary environment for large-scale production of adherent cells. Biodegradable materials used in the production of microcarriers can solve in vitro disease modeling.
Based on end user, the microcarriers market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations, and academic and research institutes. The pharmaceutical and biotechnology companies segment held the largest market share in 2022. The same segment is estimated to register the highest CAGR of 12.9% in the market during the forecast period. Pharmaceutical companies hold a major share of the total medicine production. Pharmaceutical manufacturing processes are often based on biotechnology principles that involve the use of bacteria to produce insulin, human growth hormone, and other products. Pharmaceutical and biotechnological industries have witnessed extensive growth in the past decade, mainly due to increased R&D activities and regulatory approvals for the introduction of new microbial products. Such a massive scale of innovation is projected to drive the adoption of bioreactors in pharmaceutical and biotechnological manufacturing in the coming years, eventually favoring the microcarriers market growth.
Regional Analysis:
Based on geography, the global microcarriers market is segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2022, North America contributed the largest share of the global microcarriers market size. Asia Pacific is expected to register the highest CAGR during 2022–2030.
The microcarriers market in North America is split into the US, Canada, and Mexico. The growth of the market in the region is attributed to factors such as the increasing number of product launches by biotechnology and biopharmaceutical companies, the presence of key market players, and extensive R&D by various academic and research institutes. The US is the largest contributor to the microcarriers market in North America and the world. Market growth in the US is mainly attributed to the rising prevalence of chronic diseases. As per the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as diabetes or heart disease and stroke, cancer. These diseases are the significant causes of mortality and disability in the US, and they also lead to significant costs of healthcare. There have been extensive clinical developments in the field of cell and gene therapies (CGT), owing to which the application range of these therapies has expanded in the past 5 years. With the approval of 12 new therapies and the commencement of over 2,900 clinical trials during 2016–2021, there have been extensive investments in CGT innovations. Technological advancements in gene editing, followed by clinical trials to evaluate the therapeutic effectiveness of the technique, are the other factors that have benefitted the microcarriers market in the US. Poseida Therapeutics, Inc. received the US Food and Drug Administration (FDA) approval for its Investigational New Drug (IND) application for P-CD19CD20-ALLO1—the company's first allogeneic dual CAR-T cell product candidate targeting both CD19 and CD20 antigens for the treatment of relapsed or refractory B-cell malignancies—being developed in partnership with Roche. In April 2023, Novel allogeneic CAR T-cell therapy delivered results in patients with metastatic clear cell renal cell carcinoma.
Increased participation and investments in clinical trials can accelerate the adoption and availability of new therapies. Researchers at the University of Texas MD Anderson Cancer Center led the Phase I trial and presented at the American Association for Cancer Research (AACR) Annual Meeting 2023 to represented the researchers’ continuing efforts to advance clinical studies and expand possible suggestions of approved drugs to develop a podium for more effective treatments and to improve patient outcomes. In August 2023, Astellas Pharma Inc. and Poseida Therapeutics, Inc. announced a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy. Astellas invested US$ 50 million to license one of Poseida's clinical-stage programs on P-MUC1C-ALLO1, an allogeneic CAR T-cell therapy for multiple solid tumor indications. Thus, the demand for microcarriers is on the rise in the US with the increasing number of chronic disease cases, and approval of different cell and gene therapies.
Microcarriers Market Report Scope
Industry Developments and Future Opportunities:
Various initiatives taken by leading players operating in the microcarriers market are listed below:
- In June 2023, Teijin Ltd introduced new nonwoven microcarriers for the rapidly growing large-scale cell culture. This scaffolding substance promotes three-dimensional adhesion, facilitating the growth of a variety of cell types.
- In May 2022, Saint-Gobain Life Sciences released beadMATRIX for mesenchymal stromal cells (MSCs). beadMATRIX are ready-to-use, pre-coated microcarriers free of animal components that are used to cultivate superior MSCs in vitro. Shaker bags, stirred tanks, vertical wheel bioreactors, and shaker flasks are the perfect environments for beadMATRIX.
- In June 2023, NOVA, a Saint-Gobain Life Sciences’ investment arm, announced an investment into denovoMATRIX. As an extension of the master service agreement that focuses on products related to the stem cell therapy market, both parties aimed to consolidate their relationship, thereby leveraging the global reach of Saint-Gobain Life Sciences and the innovative product line of the denovoMATRIX team.
Competitive Landscape and Key Companies:
Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, and Polysciences Inc are the prominent microcarriers market companies. These companies focus on new technologies, upgrading of existing products, and geographic expansions to meet the growing consumer demand worldwide.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Equipment, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Microcarriers Market majorly consists of the players such as Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, Polysciences Inc.
Microcarriers provide an efficient way to analyze biological data collected from different cell types. This data can be used to discover new drugs and therapies. The rising demand for automated and miniaturized products is anticipated to drive the growth of the microcarriers market. Additionally, the increasing demand for specialized products and services is also expected to contribute to the growth of the microcarrier industry.
The growth of the market is attributed to the need for cell therapies with rising incidence of cancer and infectious diseases, and increasing popularity of outsourcing cell and gene therapy manufacturing boost the market growth. However, the high cost of biologics and cell-based therapies hampers the market growth.
The Microcarriers Market is analyzed on product, equipment, application, and end users. Based on product, the market is segmented into microcarrier beads and media & reagents. Based on equipment, the market is segmented into bioreactors, culture vessels, and others. Based on application, the market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. The biopharmaceutical production segment is subsegmented into therapeutic protein and vaccine production. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations, and academic and research institutes.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Microcarriers Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Microcarriers Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.2 Market Restraints
5.2.1 High Cost of Biologics and Cell-based Therapies
5.3 Market Opportunities
5.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
5.4 Future Trends
5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
5.5 Impact Analysis
6. Microcarriers Market - Global Market Analysis
6.1 Microcarriers Market Revenue (US$ Mn), 2022 – 2030
7. Microcarriers Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Microcarrier Beads
7.3.1 Overview
7.3.2 Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Media and Reagents
7.4.1 Overview
7.4.2 Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8. Microcarriers Market – Revenue and Forecast to 2030 – by Equipment
8.1 Overview
8.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Bioreactors
8.3.1 Overview
8.3.2 Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Culture Vessels
8.4.1 Overview
8.4.2 Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9. Microcarriers Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Biopharmaceutical Production
9.3.1 Overview
9.3.2 Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.3.4 Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cell and Gene Therapy
9.4.1 Overview
9.4.2 Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Tissue Engineering and Regenerative Medicine
9.5.1 Overview
9.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
10. Microcarriers Market Revenue and Forecasts To 2030 – End User
10.1 Overview
10.2 Global Microcarriers Market Share by End User - 2022 & 2030 (%)
10.3 Pharmaceutical and Biotechnology Companies
10.3.1 Overview
10.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market– Revenue and Forecast to 2030 (US$ Million)
10.4 Contract Research Organizations and Contract Manufacturing Organizations
10.4.1 Overview
10.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Academic and Research Institutes
10.5.1 Overview
10.5.2 Academic and Research Institutes: Microcarriers Market– Revenue and Forecast to 2028 (US$ Million)
11. Microcarriers Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America Microcarriers Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America: Microcarriers Market, by Product
11.1.4 North America: Microcarriers Market, by Equipment
11.1.5 North America: Microcarriers Market, by Application
11.1.5.1 North America: Microcarriers Market, by Biopharmaceutical Production
11.1.6 North America: Microcarriers Market, by End User
11.1.7 North America: Microcarriers Market, by Country
11.1.7.1 US
11.1.7.1.1 Overview
11.1.7.1.2 US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.1.3 US: Microcarriers Market, by Product
11.1.7.1.4 US: Microcarriers Market, by Equipment
11.1.7.1.5 US: Microcarriers Market, by Application
11.1.7.1.5.1 US: Microcarriers Market, by Biopharmaceutical Production
11.1.7.1.6 US: Microcarriers Market, by End User
11.1.7.2 Canada
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.2.3 Canada: Microcarriers Market, by Product
11.1.7.2.4 Canada: Microcarriers Market, by Equipment
11.1.7.2.5 Canada: Microcarriers Market, by Application
11.1.7.2.5.1 Canada: Microcarriers Market, by Biopharmaceutical Production
11.1.7.2.6 Canada: Microcarriers Market, by End User
11.1.7.3 Mexico
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.3.3 Mexico: Microcarriers Market, by Product
11.1.7.3.4 Mexico: Microcarriers Market, by Equipment
11.1.7.3.5 Mexico: Microcarriers Market, by Application
11.1.7.3.5.1 Mexico: Microcarriers Market, by Biopharmaceutical Production
11.1.7.3.6 Mexico: Microcarriers Market, by End User
11.2 Europe Microcarriers Market, Revenue and Forecast To 2030
11.2.1 Overview
11.2.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe: Microcarriers Market, by Product
11.2.4 Europe: Microcarriers Market, by Equipment
11.2.5 Europe: Microcarriers Market, by Application
11.2.5.1 Europe: Microcarriers Market, by Biopharmaceutical Production
11.2.6 Europe: Microcarriers Market, by End User
11.2.7 Europe: Microcarriers Market, by Country
11.2.7.1 Germany
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
11.2.7.1.3 Germany: Microcarriers Market, by Product
11.2.7.1.4 Germany: Microcarriers Market, by Equipment
11.2.7.1.5 Germany: Microcarriers Market, by Application
11.2.7.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
11.2.7.1.6 Germany: Microcarriers Market, by End User
11.2.7.2 UK
11.2.7.2.1 Overview
11.2.7.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.2.3 UK: Microcarriers Market, by Product
11.2.7.2.4 UK: Microcarriers Market, by Equipment
11.2.7.2.5 UK: Microcarriers Market, by Application
11.2.7.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
11.2.7.2.6 UK: Microcarriers Market, by End User
11.2.7.3 France
11.2.7.3.1 Overview
11.2.7.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.3.3 France: Microcarriers Market, by Product
11.2.7.3.4 France: Microcarriers Market, by Equipment
11.2.7.3.5 France: Microcarriers Market, by Application
11.2.7.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
11.2.7.3.6 France: Microcarriers Market, by End User
11.2.7.4 Italy
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
11.2.7.4.3 Italy: Microcarriers Market, by Product
11.2.7.4.4 Italy: Microcarriers Market, by Equipment
11.2.7.4.5 Italy: Microcarriers Market, by Application
11.2.7.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
11.2.7.4.6 Italy: Microcarriers Market, by End User
11.2.7.5 Spain
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.5.3 Spain: Microcarriers Market, by Product
11.2.7.5.4 Spain: Microcarriers Market, by Equipment
11.2.7.5.5 Spain: Microcarriers Market, by Application
11.2.7.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
11.2.7.5.6 Spain: Microcarriers Market, by End User
11.2.7.6 Rest of Europe
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.6.3 Rest of Europe: Microcarriers Market, by Product
11.2.7.6.4 Rest of Europe: Microcarriers Market, by Equipment
11.2.7.6.5 Rest of Europe: Microcarriers Market, by Application
11.2.7.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
11.2.7.6.6 Rest of Europe: Microcarriers Market, by End User
11.3 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
11.3.1 Overview
11.3.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific: Microcarriers Market, by Product
11.3.4 Asia Pacific: Microcarriers Market, by Equipment
11.3.5 Asia Pacific: Microcarriers Market, by Application
11.3.5.1 Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
11.3.6 Asia Pacific: Microcarriers Market, by End User
11.3.7 Asia Pacific: Microcarriers Market, by Country
11.3.7.1 China
11.3.7.1.1 Overview
11.3.7.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
11.3.7.1.3 China: Microcarriers Market, by Product
11.3.7.1.4 China: Microcarriers Market, by Equipment
11.3.7.1.5 China: Microcarriers Market, by Application
11.3.7.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
11.3.7.1.6 China: Microcarriers Market, by End User
11.3.7.2 Japan
11.3.7.2.1 Overview
11.3.7.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.2.3 Japan: Microcarriers Market, by Product
11.3.7.2.4 Japan: Microcarriers Market, by Equipment
11.3.7.2.5 Japan: Microcarriers Market, by Application
11.3.7.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
11.3.7.2.6 Japan: Microcarriers Market, by End User
11.3.7.3 India
11.3.7.3.1 Overview
11.3.7.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.3.3 India: Microcarriers Market, by Product
11.3.7.3.4 India: Microcarriers Market, by Equipment
11.3.7.3.5 India: Microcarriers Market, by Application
11.3.7.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
11.3.7.3.6 India: Microcarriers Market, by End User
11.3.7.4 Australia
11.3.7.4.1 Overview
11.3.7.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
11.3.7.4.3 Australia: Microcarriers Market, by Product
11.3.7.4.4 Australia: Microcarriers Market, by Equipment
11.3.7.4.5 Australia: Microcarriers Market, by Application
11.3.7.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
11.3.7.4.6 Australia: Microcarriers Market, by End User
11.3.7.5 South Korea
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.5.3 South Korea: Microcarriers Market, by Product
11.3.7.5.4 South Korea: Microcarriers Market, by Equipment
11.3.7.5.5 South Korea: Microcarriers Market, by Application
11.3.7.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
11.3.7.5.6 South Korea: Microcarriers Market, by End User
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
11.3.7.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
11.3.7.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
11.3.7.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
11.3.7.6.6 Rest of Asia Pacific: Microcarriers Market, by End User
11.4 Middle East & Africa Microcarriers Market, Revenue and Forecast To 2030
11.4.1 Overview
11.4.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa: Microcarriers Market, by Product
11.4.4 Middle East & Africa: Microcarriers Market, by Equipment
11.4.5 Middle East & Africa: Microcarriers Market, by Application
11.4.5.1 Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.6 Middle East & Africa: Microcarriers Market, by End User
11.4.7 Middle East & Africa: Microcarriers Market, by Country
11.4.7.1 Saudi Arabia
11.4.7.1.1 Overview
11.4.7.1.2 Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
11.4.7.1.3 Saudi Arabia: Microcarriers Market, by Product
11.4.7.1.4 Saudi Arabia: Microcarriers Market, by Equipment
11.4.7.1.5 Saudi Arabia: Microcarriers Market, by Application
11.4.7.1.5.1 Saudi Arabia: Microcarriers Market, by Biopharmaceutical Production
11.4.7.1.6 Saudi Arabia: Microcarriers Market, by End User
11.4.7.2 South Africa
11.4.7.2.1 Overview
11.4.7.2.2 South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.2.3 South Africa: Microcarriers Market, by Product
11.4.7.2.4 South Africa: Microcarriers Market, by Equipment
11.4.7.2.5 South Africa: Microcarriers Market, by Application
11.4.7.2.5.1 South Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.7.2.6 South Africa: Microcarriers Market, by End User
11.4.7.3 UAE
11.4.7.3.1 Overview
11.4.7.3.2 UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.3.3 UAE: Microcarriers Market, by Product
11.4.7.3.4 UAE: Microcarriers Market, by Equipment
11.4.7.3.5 UAE: Microcarriers Market, by Application
11.4.7.3.5.1 UAE: Microcarriers Market, by Biopharmaceutical Production
11.4.7.3.6 UAE: Microcarriers Market, by End User
11.4.7.4 Rest Middle East & Africa
11.4.7.4.1 Overview
11.4.7.4.2 Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
11.4.7.4.3 Rest Middle East & Africa: Microcarriers Market, by Product
11.4.7.4.4 Rest Middle East & Africa: Microcarriers Market, by Equipment
11.4.7.4.5 Rest Middle East & Africa: Microcarriers Market, by Application
11.4.7.4.5.1 Rest Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.7.4.6 Rest Middle East & Africa: Microcarriers Market, by End User
11.5 South & Central America Microcarriers Market, Revenue and Forecast To 2030
11.5.1 Overview
11.5.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America: Microcarriers Market, by Product
11.5.4 South & Central America: Microcarriers Market, by Equipment
11.5.5 South & Central America: Microcarriers Market, by Application
11.5.5.1 South & Central America: Microcarriers Market, by Biopharmaceutical Production
11.5.6 South & Central America: Microcarriers Market, by End User
11.5.7 South & Central America: Microcarriers Market, by Country
11.5.7.1 Brazil
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
11.5.7.1.3 Brazil: Microcarriers Market, by Product
11.5.7.1.4 Brazil: Microcarriers Market, by Equipment
11.5.7.1.5 Brazil: Microcarriers Market, by Application
11.5.7.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production
11.5.7.1.6 Brazil: Microcarriers Market, by End User
11.5.7.2 Argentina
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.2.3 Argentina: Microcarriers Market, by Product
11.5.7.2.4 Argentina: Microcarriers Market, by Equipment
11.5.7.2.5 Argentina: Microcarriers Market, by Application
11.5.7.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production
11.5.7.2.6 Argentina: Microcarriers Market, by End User
11.5.7.3 Rest Of South & Central America
11.5.7.3.1 Overview
11.5.7.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.3.3 Rest Of South & Central America: Microcarriers Market, by Product
11.5.7.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment
11.5.7.3.5 Rest Of South & Central America: Microcarriers Market, by Application
11.5.7.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production
11.5.7.3.6 Rest Of South & Central America: Microcarriers Market, by End User
12. Microcarriers Market–Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Teijin Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bio-Rad Laboratories Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 denovoMATRIX GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sartorius AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Danaher Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Corning Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eppendorf SE
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Percell Biolytica AB
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Asahi Kasei Corp
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Polysciences Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
List of Tables
Table 1. Microcarriers Market Segmentation
Table 2. North America Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 3. North America Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 4. North America Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 5. North America Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 6. North America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 7. US Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 8. US Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 9. US Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 10. US Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 11. US: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 12. Canada Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 13. Canada Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 14. Canada Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 15. Canada Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 16. Canada: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. Mexico Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 18. Mexico Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 19. Mexico Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 20. Mexico Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 21. Mexico: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 22. Europe Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 23. Europe Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 24. Europe Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 25. Europe Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 26. Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 27. Germany Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 28. Germany Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 29. Germany Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 30. Germany Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 31. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 32. UK Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 33. UK Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 34. UK Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 35. UK Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 36. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 37. France Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 38. France Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 39. France Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 40. France Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 41. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 42. Italy Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 43. Italy Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 44. Italy Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 45. Italy Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 46. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 47. Spain Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 48. Spain Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 49. Spain Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 50. Spain Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 51. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 52. Rest of Europe Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 53. Rest of Europe Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 54. Rest of Europe Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 55. Rest of Europe Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 56. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 57. Asia Pacific Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 58. Asia Pacific Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 59. Asia Pacific Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 60. Asia Pacific Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 61. Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 62. China Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 63. China Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 64. China Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 65. China Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 66. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 67. Japan Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 68. Japan Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 69. Japan Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 70. Japan Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 71. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 72. India Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 73. India Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 74. India Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 75. India Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 76. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 77. Australia Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 78. Australia Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 79. Australia Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 80. Australia Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 81. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 82. South Korea Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 83. South Korea Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 84. South Korea Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 85. South Korea Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 86. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 87. Rest of Asia Pacific Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 88. Rest of Asia Pacific Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 89. Rest of Asia Pacific Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 90. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 91. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 92. Middle East & Africa Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 93. Middle East & Africa Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 94. Middle East & Africa Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 95. Middle East & Africa Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 96. Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 97. Saudi Arabia Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 98. Saudi Arabia Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 99. Saudi Arabia Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 100. Saudi Arabia Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 101. Saudi Arabia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 102. South Africa Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 103. South Africa Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 104. South Africa Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 105. South Africa Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 106. South Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 107. UAE Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 108. UAE Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 109. UAE Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 110. UAE Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 111. UAE: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 112. Rest Middle East & Africa Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 113. Rest Middle East & Africa Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 114. Rest Middle East & Africa Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 115. Rest Middle East & Africa Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 116. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 117. South & Central America Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 118. South & Central America Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 119. South & Central America Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 120. South & Central America Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 121. South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 122. Brazil Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 123. Brazil Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 124. Brazil Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 125. Brazil Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 126. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 127. Argentina Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 128. Argentina Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 129. Argentina Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 130. Argentina Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 131. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 132. Rest Of South & Central America Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 133. Rest Of South & Central America Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 134. Rest Of South & Central America Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 135. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 136. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 137. Recent Organic Growth Strategies in Microcarriers Market
Table 138. Recent Inorganic Growth Strategies in the Microcarriers Market
Table 139. Glossary of Terms
List of Figures
Figure 1. Microcarriers Market Segmentation, By Region
Figure 2. Key Insights
Figure 3. Global - PEST Analysis
Figure 4. Microcarriers Market - Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints for Microcarriers Market
Figure 6. Microcarriers Market Revenue (US$ Mn), 2022 – 2030
Figure 7. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 11. Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Global Microcarriers Market Share by End User - 2022 & 2030 (%)
Figure 22. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 23. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 24. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 25. Microcarriers Market, 2022 ($Mn)
Figure 26. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. North America: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 28. US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Microcarriers Market, 2022 ($Mn)
Figure 32. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 34. Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
Figure 35. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
Figure 38. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Microcarriers Market, 2022 ($Mn)
Figure 41. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 43. China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
Figure 44. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
Figure 47. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 49. Microcarriers Market, 2022 ($Mn)
Figure 50. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 51. Middle East & Africa: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 52. Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
Figure 53. South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
Figure 56. Microcarriers Market, 2022 ($Mn)
Figure 57. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. South & Central America: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 59. Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
Figure 60. Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
The List of Companies - Microcarriers Market
- Teijin Ltd
- Bio-Rad Laboratories Inc
- denovoMATRIX GmbH
- Sartorius AG
- Danaher Corp
- Corning Inc
- Eppendorf SE
- Percell Biolytica AB
- Asahi Kasei Corp
- Polysciences Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For